Isolation and characterisation of process-related impurities in rofecoxib

被引：12

作者：

Reddy, KVSRK

Babu, JM

Dubey, PK

Sekhar, BC

Reddy, GO

Vyas, K

机构：

[1] Dr Reddys Res Fdn, Dept Analyt Res, Hyderabad 500050, Andhra Pradesh, India

[2] JNT Univ, Dept Chem, Hyderabad 500872, Andhra Pradesh, India

[3] Dr Reddys Labs Ltd, Technol Dev Ctr, Hyderabad 500050, Andhra Pradesh, India

来源：

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | 2002年 / 29卷 / 1-2期

关键词：

rofecoxib; impurities; spectroscopy; identification and characterisation;

D O I：

10.1016/S0731-7085(02)00034-1

中图分类号：

O65 [分析化学];

学科分类号：

070302 ; 081704 ;

摘要：

Two unknown impurities in rofiecoxib bulk drug at levels below 0.1% were detected by a simple isocratic reverse phase high performance liquid chromatography (HPLC). These impurities were isolated from crude sample of rofecoxib using reverse phase preparative HPLC. H-1, C-13 and Mass spectroscopic investigations revealed the structures of the impurities as 4-[4-(methylsulphonyl)phenyll-3-phenyl-5-hydroxyfuran-2-one (1) and 4-[4-(methylsulphonyl)phenyl]-3-phenyl-2,5-furandione (11), respectively. These structures were further confirmed by prepared synthetic standards of the impurities. The tentative mechanism for the formation of these impurities was discussed. (C) 2002 Elsevier Science B.V. All rights reserved.

引用

页码：355 / 360

页数：6

共 50 条

[31] Development and Optimization of UHPLC Method for the Quantification of Process-Related Impurities of Palbociclib
Rao, Narshima
Yanamandra, Ramesh
Pradhan, Subhalaxmi
Halder, Swagata
Pradhan, Gitanjali
SEPARATION SCIENCE PLUS, 2025, 8 (03):
[32] Synthesis and Characterization of Process-Related Impurities of Antihypertensive Drug Olmesartan Medoxomil
Venkanna, G.
Madhusudhan, G.
Mukkanti, K.
Sankar, A.
Kumar, Y. Sampath
Narayana, G. Venakata
JOURNAL OF CHEMISTRY, 2013, 2013
[33] A validated UPLC method for the determination of process-related impurities in Azathioprine bulk drug
Davadra, Prakash M.
Mepal, Vivek V.
Jain, Mukul R.
Joshi, Chhelshanker G.
Bapodra, Atul H.
ANALYTICAL METHODS, 2011, 3 (01) : 198 - 204
[34] Monitoring process-related impurities in biologics-host cell protein analysis
Pilely, Katrine
Johansen, Martin Rask
Lund, Rikke Raaen
Kofoed, Thomas
Jorgensen, Thomas Kjaersgaard
Skriver, Lars
Mortz, Ejvind
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2022, 414 (02) : 747 - 758
[35] Synthesis and control of process-related impurities in the β-lactamase inhibitor drug substance zidebactam
Pund, Amit A.
Rane, Vipul P.
Raut, Vivek T.
Ahirrao, Vinod K.
Yeole, Ravindra D.
Joshi, Sanjeev
Bhavsar, Satish
Rafeeq, Mohammad
Yadav, Ramprasad
Merwade, Arvind Y.
SYNTHETIC COMMUNICATIONS, 2023, 53 (13) : 1041 - 1052
[36] Heparins: Process-related physico-chemical and compositional characteristics, fingerprints and impurities
Liverani, Lino
Mascellani, Giuseppe
Spelta, Franco
THROMBOSIS AND HAEMOSTASIS, 2009, 102 (05) : 846 - 853
[37] Process-related impurities in the ChAdOx1 nCov-19 vaccine
Krutzke, L.
Roesler, R.
Wiese, S.
Kochanek, S.
HUMAN GENE THERAPY, 2021, 32 (19-20) : A19 - A19
[38] Identification, Synthesis, and Control of Process-Related Impurities in the Antipsychotic Drug Substance Brexpiprazole
Tyagi, Rahul
Singh, Harnam
Singh, Jagat
Arora, Himanshu
Yelmeli, Vijayalaxmi
Jain, Mohit
Girigani, Sathyanarayana
Kumar, Pramod
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2018, 22 (11) : 1471 - 1480
[39] Process-Related Impurities in the ChAdOx1 nCov-19 Vaccine
Krutzke, Lea
Roesler, Reinhild
Allmendinger, Ellen
Engler, Tatjana
Wiese, Sebastian
Kochanek, Stefan
MOLECULAR THERAPY, 2022, 30 (04) : 342 - 342
[40] Isolation and characterisation of impurities in adapalene
Brenna, Elisabetta
Frigoli, Samuele
Fronza, Giovanni
Fuganti, Claudio
Sala, Federico
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 43 (03) : 1161 - 1163

← 1 2 3 4 5 →